CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. - Wikidata - wikimedia - TriplyDB

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

http://www.wikidata.org/entity/Q55466879

about

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB Cancer stem cells--the current status of an old concept: literature review and clinical approaches Targeting glioma stem cells: a novel framework for brain tumors Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.Clinical value of CD133 and nestin in patients with glioma: a population-based study.Overexpression of CD133 promotes drug resistance in C6 glioma cells.CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1 A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients.Neurosphere formation is an independent predictor of clinical outcome in malignant glioma.CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma Malignant clinical features of anaplastic gliomas without IDH mutation.CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.Targeting tumor metastases: Drug delivery mechanisms and technologies.Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.Cancer stem cells and their role in metastasis Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.Origins and clinical implications of the brain tumor stem cell hypothesis.Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.Carbon nanotubes in hyperthermia therapy.Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.The perivascular niche microenvironment in brain tumor progression.Brain tumor stem cells: the cancer stem cell hypothesis writ large.Cancer stem cells: a new framework for the design of tumor therapies.Thyroid cancer stem cells.Immunotherapy targeting glioma stem cells--insights and perspectives.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.What is the clinical value of cancer stem cell markers in gliomas?

P2860

Q24645020-AF6CCDD4-484A-4138-A78C-21281F9D4A9A Q27025165-F78EF7F3-E484-4F78-AD1E-E89D52F869C8 Q27026818-D1B67177-9084-40DE-BF43-58D90896C3BE Q30388310-F8246BEE-79C8-4318-B19D-8CCB33B9D8CB Q30413140-C7129F7F-194C-4AF5-A479-2BFABDE6086B Q30426915-B3AA77DE-B560-401B-BD1E-2C4284F8EC24 Q33794878-467D5A78-8E6D-4EDE-9E2C-DC01D462C5E1 Q33974370-AEFED957-FE9E-472E-9350-6240AFCB2986 Q34028947-334C0A12-0452-4F51-A491-5E9B8013A66F Q34073309-DB4720F8-B8FB-471E-B22A-A2B5F26DCDFA Q34091227-6585D86E-88D2-4887-8B6D-D4932CCD069F Q34128316-AC78EF9D-5EB0-4B0D-AE91-897620E987E4 Q34132833-9FDC784E-B319-406D-B597-8A9BC8846AA7 Q34154786-037E1C60-AFBA-417B-BF31-6A6717DD3CB3 Q34269290-FECA70A3-3A3C-4075-921F-6F8D12C008A8 Q34486691-28021F2A-F622-4CDB-95D0-75BEE1CA22AA Q34635517-AE03CD39-9FF0-44A6-8D52-CE46AC435F07 Q34785641-5A2E5812-DBA3-464B-8244-62FD68A2B787 Q35224959-C15834E1-4C7D-46FF-B23E-D5F3F8DB515B Q35422357-803310D1-D5B0-46A2-A609-7BBFD403C126 Q35440815-766CEA7F-88A7-413A-A945-5659C09E2052 Q35788726-4CB4313C-8392-4E3C-B743-0EE79D746915 Q36041205-CA115E68-4E8D-411F-BE8B-5B420EC2C6E0 Q36552798-3453D72E-7E01-440B-AF47-9BD344113D4B Q36557855-E57A0075-EA01-4755-BF47-436260426017 Q36661089-8C9C6EB2-90B2-4C28-8D3B-73F04BC92CFF Q36698757-6C42B136-E091-4F06-8078-4DCAC6FE5A97 Q36861550-29EB0490-79EF-449D-ABA1-A99AC48312A2 Q37077666-A0CD0581-A5D6-405B-AE8F-103F80AA7C02 Q37230949-D3DAA0CB-B268-4C59-821F-A74783AB980D Q37231529-BA954B0D-91FF-4E82-9EA3-B5F7469C19DC Q37557801-593D3248-20DD-4527-AA89-30560B74820D Q37629613-80D14E27-070C-4A2D-A2CF-3FCA91CF38DC Q37780433-D991F145-00D8-46A1-8E4E-F2E3A0E31674 Q37783774-6F3BC73C-FDC8-4FA3-9A56-B2332506ACA4 Q37796629-3C8FC317-342D-4C2E-AD56-35F92D475A94 Q37905534-68C27261-3ED3-40B1-9254-83880713F6FA Q37971408-A5BEEB5F-05CE-4692-A640-42FBB7ADBE95 Q38035206-E21564BD-DD60-4AC7-904D-A2CE7F5F9932 Q38081776-006B6247-99D5-44BA-8B5D-D4FF8C8693C8

P2860

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

http://www.wikidata.org/entity/Q55466879

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@en

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@nl

type

label

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@en

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@nl

prefLabel

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@en

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@nl

P1433

Q55466879-44B0AB6B-04BA-44D4-8ECB-E4ECEDA55354

P1476

Q55466879-9DE72170-74DA-424F-B4BC-801089AB686B

P2093

Q55466879-1FA94F86-12AF-47EB-A39B-8F8E99196CB7

Q55466879-41DC8027-A576-4186-844D-81674FDF6DF7

Q55466879-496728B3-3EA7-41FD-A4B3-51091BC8EF2B

Q55466879-5587F707-2F4D-4442-95B8-6669CE6C7847

Q55466879-95640D24-D0ED-42E9-BAF3-5105BE259B44

Q55466879-B86BE249-F902-4359-A5CA-5299BCA11976

Q55466879-C74A7F06-B6C7-41C5-8D71-B0B68610F6D1

P2860

Q55466879-03D7BED7-0975-43B2-BEB7-57419323A0E8

Q55466879-17D853AE-3E4D-484D-A720-97D1EFC1650C

Q55466879-19AE101B-96A2-41EE-BE65-04D3F78414E9

Q55466879-1B0453FF-E7FF-4E84-A5C2-3FC4C51189C4

Q55466879-20402A75-1F20-446A-A2E8-63ECAAC8ACA5

Q55466879-39D7FC39-7847-4FA0-B2E3-FD10C1543A17

Q55466879-49DBC640-450F-4C5F-9419-B75AA4F5574D

Q55466879-5AAFAA43-4013-4D8A-956A-0461A64AC638

Q55466879-63CAA6CF-7BB8-4393-8B77-4D5CBA1D51E9

Q55466879-7018696F-FFCE-4913-88B8-767CC659CD4E

P304

Q55466879-0E847C13-D788-43CA-8E93-E6286D91EFD5

P31

Q55466879-13E4C20B-B4DB-440F-9AA2-31FD26B20AD1

P356

Q55466879-119B3B6D-72DB-4CD0-BB2C-FCA833982E5B

P433

Q55466879-A0E934EB-54F8-47EE-810F-B8029BAEB9D5

P478

Q55466879-E8593E0C-2F90-4FD8-9E34-3EDBAA6BE5C2

P50

Q55466879-6405D0A5-5289-45D6-925D-804329049A62

P577

Q55466879-A57AA5D8-6A77-47AB-A383-EDDE3095DAD0

P5875

Q55466879-7FF83CA2-EA61-4EF0-BB4D-81C09D56DE29

P698

Q55466879-B8C2415D-7F0F-4986-80C9-0C5C79C7A7BD

P921

Q55466879-C92E6435-7B93-4583-A58C-0ACB66897654

P356

J.1750-3639.2008.00130.X

P1433

Brain Pathology

P1476

CD133 expression and cancer st ...... grade oligodendroglial tumors.

@en

P2093

Alexander Brawanski

http://www.w3.org/2001/XMLSchema#string

Christoph P Beier

http://www.w3.org/2001/XMLSchema#string

Dagmar Beier

http://www.w3.org/2001/XMLSchema#string

Martin Proescholdt

http://www.w3.org/2001/XMLSchema#string

Peter Hau

http://www.w3.org/2001/XMLSchema#string

Ulrich Bogdahn

http://www.w3.org/2001/XMLSchema#string

Wolfgang Dietmaier

http://www.w3.org/2001/XMLSchema#string

P2860

Cancerous stem cells can arise from pediatric brain tumors

The 2007 WHO classification of tumours of the central nervous system

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Stem cells, cancer, and cancer stem cells

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of human brain tumour initiating cells

Direct isolation of human central nervous system stem cells

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity.

Glial progenitors in the CNS and possible lineage relationships among them.

P304

370-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1750-3639.2008.00130.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Jörg Wischhusen

P577

2008-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5481812

http://www.w3.org/2001/XMLSchema#string

P698

18371181

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte